• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

准分子激光角膜切削术与准分子原位角膜磨镶术治疗中高度近视的随机前瞻性研究。

Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.

作者信息

Hersh P S, Brint S F, Maloney R K, Durrie D S, Gordon M, Michelson M A, Thompson V M, Berkeley R B, Schein O D, Steinert R F

机构信息

Department of Ophthalmology, UMDNJ-New Jersey Medical School, Newark, USA.

出版信息

Ophthalmology. 1998 Aug;105(8):1512-22, discussion 1522-3. doi: 10.1016/S0161-6420(98)98038-1.

DOI:10.1016/S0161-6420(98)98038-1
PMID:9709767
Abstract

OBJECTIVE

This report presents the results of a randomized clinical trial of photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK).

DESIGN

A randomized, prospective multicenter clinical trial.

PARTICIPANTS

A total of 220 eyes of 220 patients entered the study cohort: 105 randomized to PRK and 115 to LASIK. The mean preoperative manifest refraction spherical equivalent was -9.23 diopters (D) in the PRK group and -9.30 D in the LASIK group.

INTERVENTION

All patients received a one-pass, multizone excimer laser ablation as part of either a PRK or LASIK procedure using the Summit Apex excimer laser. Attempted corrections ranged from 6.00 to 15.00 D.

MAIN OUTCOME MEASURES

Data on uncorrected and spectacle-corrected visual acuity, predictability,and stability of refraction, corneal haze, and flap complications were analyzed. Patients were observed for up to 6 months.

RESULTS

One day after surgery, 0 (0.0%) and 3 (4.5%) eyes in the PRK group saw 20/20 and 20/40 or better uncorrected, respectively, while 7 (10%) and 48 (68.6%) eyes in the LASIK group saw 20/20 and 20/40 or better, respectively. At 6 months after PRK, 13 (19.1%) and 45 (66.2%) eyes saw 20/20 and 20/40 or better, respectively, while after LASIK, 16 (26.2%) and 34 (55.7%) eyes saw 20/20 and 20/40 or better, respectively (odds ratio = 0.56 for likelihood of uncorrected visual acuity < 20/40 for PRK vs. LASIK, 95% confidence interval [CI] = 0.31-1.19). After PRK, 39 eyes (57.4%) were within 1.0 D of attempted correction compared with 24 eyes (40.7%) in the LASIK group (odds ratio = 0.50 for likelihood fo undercorrection 1.0 D for PRK vs. LASIK, 95% CI = 0.24-1.04); however, the standard deviation of the predictability was similar between groups: 1.01 D for PRK and 1.22 D for LASIK. From months 1 to 6, there was an average regression of 0.89 D in the PRK group and 0.55 D in the LASIK group. After PRK, eight eyes (11.8%) had a decrease in spectacle-corrected visual acuity of two Snellen lines or more; after LASIK, two eyes (3.2%) had a decrease of two lines or more (odds ratio = 3.89 for risk of loss of spectacle-corrected visual acuity for PRK vs. LASIK, 95% CI = 0.71-21.30). Only two eyes had postoperative spectacle-corrected visual acuity less than 20/32, however.

CONCLUSIONS

Although improvement in uncorrected visual acuity is more rapid in LASIK than in PRK, efficacy outcomes in the longer term generally are similar between the two procedures. There is a greater tendency toward undercorrection in LASIK eyes using the specific laser and nomogram in this study, but the scatter in achieved versus attempted correction is similar, suggesting little difference in the accuracy of the two procedures. A suggestion of decreased propensity for loss of spectacle-corrected visual acuity in LASIK eyes requires further investigation.

摘要

目的

本报告展示了准分子激光角膜切削术(PRK)和准分子原位角膜磨镶术(LASIK)随机临床试验的结果。

设计

一项随机、前瞻性多中心临床试验。

参与者

共有220例患者的220只眼进入研究队列:105只眼随机分配至PRK组,115只眼随机分配至LASIK组。PRK组术前平均显性验光等效球镜度数为-9.23屈光度(D),LASIK组为-9.30 D。

干预

所有患者均接受单次、多区准分子激光消融,作为使用Summit Apex准分子激光进行PRK或LASIK手术的一部分。尝试的矫正范围为6.00至15.00 D。

主要观察指标

分析未矫正和 spectacle 矫正视力、屈光预测性和稳定性、角膜 haze 以及瓣并发症的数据。对患者进行长达6个月的观察。

结果

术后1天,PRK组分别有0只眼(0.0%)和3只眼(4.5%)未矫正视力达到20/20及20/40或更好,而LASIK组分别有7只眼(10%)和48只眼(68.6%)未矫正视力达到20/20及20/40或更好。PRK术后6个月,分别有13只眼(19.1%)和45只眼(66.2%)未矫正视力达到20/20及20/40或更好,而LASIK术后,分别有16只眼(26.2%)和34只眼(55.7%)未矫正视力达到2 (20/20及20/40或更好(PRK与LASIK相比,未矫正视力<20/40的可能性的优势比=0.56,95%置信区间[CI]=0.31 - 1.19)。PRK术后,39只眼(57.4%)在尝试矫正的1.0 D范围内,而LASIK组为24只眼(40.7%)(PRK与LASIK相比,欠矫1.0 D的可能性的优势比=0.50,95% CI = 0.24 - 1.04);然而,两组之间预测性的标准差相似:PRK为1.01 D,LASIK为1.22 D。从第1个月到第6个月,PRK组平均回退0.89 D, LASIK组平均回退0.55 D。PRK术后,8只眼(11.8%) spectacle 矫正视力下降2行或更多;LASIK术后,2只眼(3.2%)下降2行或更多(PRK与LASIK相比, spectacle 矫正视力丧失风险的优势比=3.89,95% CI = 0.71 - 21.30)。然而,只有2只眼术后 spectacle 矫正视力低于20/32。

结论

尽管LASIK术后未矫正视力的改善比PRK更快,但两种手术的长期疗效结果总体相似。使用本研究中的特定激光和列线图,LASIK眼有更大的欠矫倾向,但实际矫正与尝试矫正的离散度相似,表明两种手术的准确性差异不大。LASIK眼 spectacle 矫正视力丧失倾向降低的迹象需要进一步研究。

相似文献

1
Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.准分子激光角膜切削术与准分子原位角膜磨镶术治疗中高度近视的随机前瞻性研究。
Ophthalmology. 1998 Aug;105(8):1512-22, discussion 1522-3. doi: 10.1016/S0161-6420(98)98038-1.
2
Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group.用于中高度近视的球面和非球面光性屈光性角膜切削术及准分子原位角膜磨镶术:两项前瞻性随机临床试验。Summit技术公司PRK-LASIK研究组
Trans Am Ophthalmol Soc. 1998;96:197-221; discussion 221-7.
3
Randomized bilateral comparison of excimer laser in situ keratomileusis and photorefractive keratectomy for 2.50 to 8.00 diopters of myopia.准分子激光原位角膜磨镶术与屈光性角膜切削术治疗2.50至8.00屈光度近视的随机双侧比较
Ophthalmology. 1999 Mar;106(3):447-57. doi: 10.1016/S0161-6420(99)90102-1.
4
Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia.准分子激光原位角膜磨镶术和准分子激光角膜切削术治疗高度近视。
J Refract Corneal Surg. 1994 Sep-Oct;10(5):498-510.
5
Comparison of photorefractive keratectomy with excimer laser in situ keratomileusis in correcting low myopia (from -2.00 to -5.50 diopters). A randomized study.准分子激光原位角膜磨镶术与准分子激光角膜切削术矫正低度近视(-2.00至-5.50屈光度)的比较:一项随机研究。
Ophthalmology. 1999 Feb;106(2):411-20; discussion 420-1. doi: 10.1016/S0161-6420(99)90084-2.
6
Laser in situ keratomileusis for moderate and high myopia and myopic astigmatism.准分子原位角膜磨镶术治疗中高度近视及近视散光。
Ophthalmology. 1998 May;105(5):932-40. doi: 10.1016/S0161-6420(98)95040-0.
7
Laser in situ keratomileusis versus surface ablation: visual outcomes and complications.准分子原位角膜磨镶术与表面切削术:视觉效果及并发症
J Cataract Refract Surg. 2007 Dec;33(12):2041-8. doi: 10.1016/j.jcrs.2007.07.026.
8
Excimer laser in-situ keratomileusis (LASIK) under a corneal flap for myopia of 2 to 20 D.角膜瓣下准分子激光原位角膜磨镶术(LASIK)治疗2至20屈光度的近视。
Trans Am Ophthalmol Soc. 1995;93:163-83; discussion 184-90.
9
Photorefractive keratectomy for low-to-moderate myopia and astigmatism with a small-beam, tracker-directed excimer laser.使用小光斑、跟踪导向准分子激光进行的光性屈光性角膜切削术治疗中低度近视和散光。
Ophthalmology. 1999 Aug;106(8):1481-8; discussion 1488-9. doi: 10.1016/S0161-6420(99)90440-2.
10
Excimer laser photorefractive keratectomy and laser in situ keratomileusis for myopia and astigmatism.准分子激光屈光性角膜切削术和准分子激光原位角膜磨镶术治疗近视和散光。
J Med Assoc Thai. 2000 Feb;83(2):182-92.

引用本文的文献

1
A Two-Decade Bibliometric Analysis of Laser in Ophthalmology: From Past to Present.眼科激光领域二十年文献计量分析:从过去到现在
Clin Ophthalmol. 2024 May 13;18:1313-1328. doi: 10.2147/OPTH.S458840. eCollection 2024.
2
Bibliometric and visualized analysis of myopic corneal refractive surgery research: from 1979 to 2022.1979年至2022年近视角膜屈光手术研究的文献计量学与可视化分析
Front Med (Lausanne). 2023 Jul 28;10:1141438. doi: 10.3389/fmed.2023.1141438. eCollection 2023.
3
Comparison of Iris-Claw Phakic Lens Implant versus Corneal Laser Techniques in High Myopia: A Five-Year Follow-Up Study.
高度近视患者中虹膜夹型有晶状体眼人工晶状体植入术与角膜激光技术的比较:一项五年随访研究
Healthcare (Basel). 2022 Sep 28;10(10):1904. doi: 10.3390/healthcare10101904.
4
Intraocular lens power calculation in eyes with previous corneal refractive surgery.既往接受过角膜屈光手术的眼睛的人工晶状体度数计算
Ther Adv Ophthalmol. 2022 Aug 30;14:25158414221118524. doi: 10.1177/25158414221118524. eCollection 2022 Jan-Dec.
5
Posterior chamber phakic intraocular lens implantation after laser in situ keratomileusis.准分子激光原位角膜磨镶术后后房型有晶状体眼人工晶状体植入术
Eye Vis (Lond). 2022 Apr 11;9(1):15. doi: 10.1186/s40662-022-00282-6.
6
Three-Year Follow-Up of Laser In Situ Keratomileusis Treatments for Myopia: Multi-Center Cohort Study in Korean Population.近视激光原位角膜磨镶术治疗的三年随访:韩国人群多中心队列研究
J Pers Med. 2021 May 16;11(5):419. doi: 10.3390/jpm11050419.
7
The Prevalence of Infectious Keratitis after Keratorefractive Surgery: A Systematic Review and Meta-Analysis Study.角膜屈光手术后感染性角膜炎的患病率:一项系统评价和荟萃分析研究
J Ophthalmol. 2020 Jul 28;2020:6329321. doi: 10.1155/2020/6329321. eCollection 2020.
8
Calzone-Like Traumatic Flap Dislocation Four Years after Laser in situ Keratomileusis.准分子激光原位角膜磨镶术后四年出现的类似卡尔佐内的外伤性皮瓣脱位
Case Rep Ophthalmol. 2019 Aug 13;10(2):281-286. doi: 10.1159/000502283. eCollection 2019 May-Aug.
9
Immediate and short term visual recovery after SmartSurf photorefractive keratectomy.SmartSurf准分子激光角膜切削术后的即时和短期视力恢复
J Optom. 2019 Oct-Dec;12(4):240-247. doi: 10.1016/j.optom.2019.04.003. Epub 2019 Aug 28.
10
Very late-onset flap margin corneal ulcer following laser in situ keratomileusis.准分子原位角膜磨镶术后迟发性角膜瓣边缘溃疡
Int Ophthalmol. 2019 Nov;39(11):2533-2538. doi: 10.1007/s10792-019-01100-0. Epub 2019 Apr 13.